The US Food and Drug Administration (FDA) has introduced a proposal to require a front-of-pack nutrition label for most packaged foods. This initiative aims to assist consumers in identifying healthier food options.
This action contributes to the US government’s broader efforts to address chronic diseases such as heart disease, diabetes, and cancer, which are among the leading causes of death and disability in the country.
In 2022, US President Joe Biden unveiled a plan aimed at combating diet-related diseases through the establishment of a front-of-package labeling system.
If finalized, the Nutrition Info box will indicate whether a product’s saturated fat, sodium, and added sugars content is “low,” “medium,” or “high.” This proposal mirrors the existing Nutrition Facts label, which provides detailed nutrient information for packaged foods sold in the US.
Per the FDA’s announcement on 14 January, manufacturers with annual sales exceeding $10 million will have three years to comply, while smaller businesses will be allotted four years. Additionally, the regulator has initiated a feedback period, open until 16 May.
FDA commissioner Robert Califf stated, “Nearly everyone knows or cares for someone with a chronic disease that is due, in part, to the food we eat. It is time we make it easier for consumers to glance, grab and go.
“Adding front-of-package nutrition labeling to most packaged foods would do that. We are fully committed to pulling all the levers available to the FDA to make nutrition information readily accessible as part of our efforts to promote public health.”
The FDA has cited studies indicating that many ultra-processed foods available in the US are high in saturated fat, sodium, and added sugars.
Jennifer Hatcher, chief public policy officer of the Food Industry Association (FMI), characterized the proposal as “the best-suited scheme.”
However, she expressed concerns regarding the logistics of implementing the proposal, highlighting that the “FOP scheme would be required to appear in the upper third of the principal display panel.”
This requirement, she noted, would necessitate “redesigning of most packaging labels” and could potentially “displace” critical information such as date labels, which are essential for informed consumer choices.
Hatcher emphasized that such substantial changes would lead to increased costs with limited public health benefits.
Dr. Peter Lurie, president of the US NGO Center for Science in the Public Interest, referred to the proposal as “long overdue,” highlighting its “potential to usher in healthier consumer purchases, incentivize companies to produce healthier products, and stem the rising tide of preventable conditions like type 2 diabetes and heart disease.”
Dr. Lurie expressed hope that when the FDA finalizes the policy, it will consider the growing “international evidence” supporting the “High In”-style labels adopted by other countries, particularly in South America.
